(Total Views: 502)
Posted On: 10/25/2019 2:12:52 PM
Post# of 36564
Generex Biotechnology Announces Investor Conference Call Scheduled for Tuesday October 29, 2019 at 9:30 AM
2:06 PM ET, 10/25/2019 - GlobeNewswire
MIRAMAR, Fla., Oct. 25, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced that it will hold an investor conference call on Tuesday October 29, 2019 at 9:30 am.
Joseph Moscato, Generex President & Chief Executive Officer stated: “I look forward to this conference call and invite all of our valuable shareholders to attend.”
Dial-in instructions for the investor conference call will be announced prior to the meeting date.
About Generex Biotechnology Corp.Generex Biotechnology is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. Generex is building a new kind of healthcare company that extends beyond traditional models providing support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care.
In addition to advancing a legacy portfolio of immune-oncology assets, medical devices, and diagnostics, the Company is focused on an acquisition strategy of strategic businesses that complement existing assets and provide immediate sources of revenue and working capital. Recent acquisitions include a management services organization, a network of pharmacies, clinical laboratory, and medical device companies with new and approved products.
2:06 PM ET, 10/25/2019 - GlobeNewswire
MIRAMAR, Fla., Oct. 25, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced that it will hold an investor conference call on Tuesday October 29, 2019 at 9:30 am.
Joseph Moscato, Generex President & Chief Executive Officer stated: “I look forward to this conference call and invite all of our valuable shareholders to attend.”
Dial-in instructions for the investor conference call will be announced prior to the meeting date.
About Generex Biotechnology Corp.Generex Biotechnology is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. Generex is building a new kind of healthcare company that extends beyond traditional models providing support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care.
In addition to advancing a legacy portfolio of immune-oncology assets, medical devices, and diagnostics, the Company is focused on an acquisition strategy of strategic businesses that complement existing assets and provide immediate sources of revenue and working capital. Recent acquisitions include a management services organization, a network of pharmacies, clinical laboratory, and medical device companies with new and approved products.
(2)
(0)
